Blue Horizon’s Post

After months in the works, today our team is excited to announce our new report in collaboration with The Boston Consulting Group (BCG) that sheds light on the path for #biomanufacturing to reach $200 billion in speciality markets over next decade. The report offers detailed insights for transitioning the global economy to more sustainable, efficient, and cost-effective methods of production and points to next-generation biofoundries as key catalysts for the coming wave of superior products. Demand is solidifying for bioproducts, which leverage the power of engineered microorganisms and biological processes in place of traditional production methods. But for change to happen, costs must come down. Key insights from the report include: 🔎Optimized large-scale facilities can lower production costs by as much as 50% on existing strains. 🔎More and larger facilities and improved strains could reduce production costs by up to 90%, achieving or surpassing price parity with incumbent methods for most products. 🔎 The market for biomanufactured ingredients in three industries alone—specialty chemicals, food, and chemical precursors could reach $200 billion by 2040. Dive into our insights and learn more here: https://lnkd.in/eGXcf-h9 #sustainability #bioeconomy #fermentation #precisionfermentation #bioproducts #biomaterials #biomassfermentation #climate #alternativeproteins #foodtech #specialtychemicals

🌍 The market that will open up to startups that manage to bring down the cost of manufacturing bioproducts 🏭 is simply immense 😳.  👉 This is precisely the objective of Catsalyze, thanks to its proprietary technology. And with enzymatic biocatalysis. The #reindustrialization of #France begins with the production in France of biosourced and cleanly produced chemical molecules. Thank you Synonym and Boston Consulting Group (BCG) SAYENS Alexis Boutilliat Incubateur Lorrain Natacha Hauser-Costa ADEME Bruno Bonnell Bpifrance France Deeptech Abdelkader GUELLIL Damien Debecker Florent Allais, FRSC France Chimie Chemtech Bioeconomy For Change Romain Foussadier Brice Gianesini NetZero Team for the Planet Anaïs Voy-Gillis Nicolas Dufourcq

Here we go - some thoughts around #biomanufacturing from Synonym and Boston Consulting Group (BCG) and the cost barriers. A few good ideas included, and a good write-up also for financial or economic driven colleagues, not only us geek #engineers. I am happy to share in my network. download for free and share your thoughts. A bit confusing to me is the use of the term "biofoundries" in the report, where they call it: (quote) "These in turn require construction and optimization of biofoundries—large-scale, standardized biomanufacturing facilities that can meet industrial-level demand— and continued improvements in strain engineering."(end quote) While I can agree to a good extent to the need of such hubs / sites, the term "biofoundry" has been coined and is recognized by most people to be a highly automated and computer aided DBTL infrastructure, capable of escalating (not always accelerating) the synthetic biology workflow towards improved strain geno- and phenotypes. Also "precision fermentation" is a term used to allow the food industry (in the advent of alternative proteins showing up again and saw traction) to differentiate from their fermentation (like prebiotics or beer) with the way the rest of the world ferments (pharma, chemistry, etc). Its a bit misleading in my opinion, and leaned towards the food sector primarily. #biotechnology #scaleup

Synonym : Very interesting publication for a very relevant issue. But if I am not wrong it seems that the meaning of #Biofoundry adopted in this report is a little bit confusing. Instead using #Biomanufacturing facility would be more appropriate. Actually biofoundry stands for a dedicated unit for designing strains 🆚 biomanufacturing plant which is a facility for implementing these engineered strains at industrial scale for producing a broad range of bioproducts

Are bioproducts made from precision fermentation processes—long predicted to disrupt industries from pharmaceuticals to food to chemicals—finally on the verge of achieving their potential? Thanks to our research with the Boston Consulting Group (BCG), we're optimistic that it's possible to solve this multi-decade conundrum! Demand is solidifying for products that use biological processes and genetically modified microorganisms in place of traditional production methods. But for change to happen, costs must come down. Biomanufacturing is paving the way to a sustainable future, with potential to cut production costs by 50-90%. In our recent report with the Boston Consulting Group (BCG), our findings highlight a booming $200B opportunity across specialty chemicals, food, and chemical precursors by 2040. Success hinges on corporate action towards #sustainability and net zero goals. Explore our report for more on the key strategies https://lnkd.in/eGXcf-h9 #sustainability #bioeconomy #precisionfermentation #bioproducts #biomaterials #alternativeproteins #foodtech #netzero #materialstransition

💡 The market for biomanufactured ingredients in three industries - specialty chemicals, food, and chemical precursors - could reach $200 billion by 2040 - if the manufacturing capacity is there After launching a collaborative report with Boston Consulting Group (BCG) Group on ‘Breaking the Cost Barrier on Biomanufacturing’, Synonym are hosting a session with an incredible lineup of policymakers, industry leaders and experts on scaling biomanufacturing and the importance of policy in accelerating the global shift. John Cumbers, Co-founder, SynBioBeta Jean-Francois Bobier, Partner & Director, Boston Consulting Group (BCG) Jake Auchincloss, U.S. Congressman Brentan Alexander, Chief Investment Officer, Synonym Maarit Nyman, Subject Matter Expert, European Commission Be sure to register and dial in! 📅 Date: June 6, 2024 🕒 Time: 4 pm CET 📍 Register: https://lnkd.in/dX3G6gVh 📈 Full report here: https://lnkd.in/eGXcf-h9 #bioeconomy #sustainability #futurefood #scaleup

Compelling report from Boston Consulting Group (BCG) and Synonym contributors, including Jean-Francois Bobier, Tristan Cerisy, PhD, Anne-Douce Coulin Kuhlmey, Crystal Bleecher, PE, Victoria Sassoon and Brentan Alexander, on bringing costs down in biomanufacturing. A worthy goal considering the estimate that “scaling up industrial precision fermentation can create a $200 billion market by 2040, seven times the current size, if companies build enough production capacity to lower costs.” As demand for products that use bioalternatives grows, driven by the desire to build sustainable manufacturing processes while reducing carbon emissions, the need for large-scale, biomanufacturing facilities that can meet industrial-level demand and cost-targets grows. Creating this capacity is why Manus built one of the largest piloting and large-scale manufacturing BioFacilities in the Americas. Providing the opportunity for large-scale manufacturing and optimizing strains with large-scale manufacturing in mind are both integral for efficient scaling and cost-effective biomanufacturing. Read the full report: https://lnkd.in/eGXcf-h9 Learn more about our scale-up capabilities: https://bit.ly/42Yd1iB #bioeconomy #biomanufacturing #biotechnology #syntheticbiology #MadeByManus

Fermentation chemicals are poised to revolutionize green chemistry by offering sustainable alternatives to fossil-based synthetics. Our latest report explores the production, applications, and market growth potential of bio-based chemicals like lactic acid, ethanol, and citric acid produced through microbial processes. These chemicals can significantly reduce carbon emissions and provide constant supply without competing with food resources. Leading companies such as NatureWorks, Geno Pond Technologies Inc., Roquette, Cyanotech Corporation, Evonik, Danimer Scientific, Itaconix Corporation, Procter & Gamble, Cargill, Unilever, SEKISUI CHEMICAL, Novozymes OneHealth, and BASF are at the forefront of this innovation. The market is expected to grow rapidly, potentially reaching billion-dollar valuations by 2030. To read more, access our report (link in the comments) by Marija Jović, Laís Pereira Silva, and Priscila da Costa Carvalho de Jesus. #FermentationChemicals #GreenChemistry #SustainableTech #PreScouter

Recent technological advancements in fermentation processes are bringing bioplastics back into the spotlight. According to a new report by PreScouter, Inc., fermentation chemicals are showing increased potential to become the next disruptor in the green chemistry revolution. In this article, Mariam Jomha, PreScouter Marketing Director, examines the report’s key findings and the expanding role & applications of fermentation chemicals in the packaging industry Click here to read: https://lnkd.in/eSvEEC4Q To get access to exclusive premium content, become a Packaging Europe member: https://lnkd.in/em_Jz4_Q   Follow our hashtag to stay up to date with the latest packaging news: #PackagingEurope

A revolution in the personal hygiene industry? ZymoChem unveils world's first scalable, 100% #biobased, and #biodegradable super absorbent polymer! BAYSE™ is said to revolutionise the $145 billion global hygiene industry and pave the way for a more sustainable future, being a direct, sustainable replacement for conventional, petroleum-derived super-absorbent #polymers (SAPs). Their proprietary technology is a fermentation platform of carbon conserving (C2) microbes that convert #renewable feedstocks into high-value materials while minimising carbon dioxide loss. They claim it enables the production of BAYSE™ at scale, at a cost competitive price. *image by macrovector / Freepik